{rfName}
Ne

Indexed in

License and use

Icono OpenAccess

Citations

8

Altmetrics

Analysis of institutional authors

Molina-Andujar AAuthorPiñeiro GjAuthorCucchiari DAuthorPoch EAuthor

Share

September 8, 2023
Publications
>
Review

New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide

Publicated to:Front Nephrol. 2 879766-879766 - 2022-01-01 2(), DOI: 10.3389/fneph.2022.879766

Authors: Escudero VJ; Mercadal J; Molina-Andújar A; Piñeiro GJ; Cucchiari D; Jacas A; Carramiñana A; Poch E

Affiliations

Abstract

Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used with good results in patients with selected profiles. From acetazolamide to tolvaptan, we will discuss recent studies and highlight how specific diuretic mechanisms could help to manage different ICU problems, such as loop diuretic resistance, hypernatremia, hyponatremia, or metabolic alkalosis. The current review tries to shed some light on the potential use of non-loop diuretics based on patient profile and give recommendations for loop diuretic treatment performance focused on what the intensivist and critical care nephrologist need to know based on the current evidence. Copyright © 2022 Escudero, Mercadal, Molina-Andújar, Piñeiro, Cucchiari, Jacas, Carramiñana and Poch.

Keywords

Acute kidney injuryCongestionDiureticsFluid overloadIntensive care unit

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 4.52, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-18, the following number of citations:

  • Scopus: 4

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-18:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 74.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 75 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 318.
  • The number of mentions on the social network X (formerly Twitter): 522 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Escudero VJ) and Last Author (Poch Lopez de Briñas, Esteban).